BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4273394)

  • 1. Inhibition of cellular immune reactions by cyclophosphamide analogues ifosfamide and trofosfamide. I. Mixed lymphocyte reaction.
    Devlin RG; Schwartz NL; Baronowsky PE; Zygmunt WA
    Proc Soc Exp Biol Med; 1974 Feb; 145(2):389-91. PubMed ID: 4273394
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunosuppressive properties of cyclophosphamide analogues.
    Harrison EF; Fuquay ME
    Proc Soc Exp Biol Med; 1972 Mar; 139(3):957-63. PubMed ID: 5063370
    [No Abstract]   [Full Text] [Related]  

  • 3. [Animal experiments on the anti-inflammatory and immunosuppressive effect of cytostatic agents].
    Müller US; Wirth W; Thöne F; Junge-Hülsing G; Hauss WH
    Arzneimittelforschung; 1973 Apr; 23(4):487-91. PubMed ID: 4268068
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacological studies with alkylsulfonyloxyalkyl substituted and chloroethyl substituted oxazaphosphorine-2-oxides. 2. Pharmacological characterization of 2-alkylsulfonyl-oxyalkylamino-oxazaphosphorine-2-oxides including immunological reaction].
    Arzneimittelforschung; 1974 Aug; 24(8):1149-60. PubMed ID: 4371545
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of cyclophosphamide and cyclophosphamide plus acetylcysteine on the in vivo-in vitro mixed lymphocyte reaction.
    Devlin RG; Schwartz NL; Mackey HK; Baronowsky PE
    Transplantation; 1974 Jan; 17(1):70-4. PubMed ID: 4271943
    [No Abstract]   [Full Text] [Related]  

  • 6. Synergistic response between thymus and lymph node cells in the mixed lymphocyte culture.
    Tittor W; Walford RL
    Nature; 1974 Feb; 247(5440):371-3. PubMed ID: 4274156
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of cyclophosphamide and other homologous oxazaphosphorine-2-oxides on transplantation-immunologic reactions].
    Müller-Ruchholtz W
    Arzneimittelforschung; 1974 Aug; 24(8):1160-7. PubMed ID: 4370872
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacological studies with alkylsulfonyloxyalkyl substituted and chloroethyl substituted oxazaphosphorine-2-oxides. 1. Communication: relationship between chemical structure and pharmacological action.
    Brock N; Kuhlmann J
    Arzneimittelforschung; 1974 Aug; 24(8):1139-49. PubMed ID: 4371234
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative study of cyclophosphamide, ifosfamide and trofosfamide on Walker-256 carcinosarcoma in embryonated chicken eggs].
    Norpoth K; Witting U; Rauen HM
    Arzneimittelforschung; 1974 Jan; 24(1):86-9. PubMed ID: 4406116
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunosuppression through alkylating agents: hints on the superiority of 5122 ASTA to cyclophosphamide].
    Botzenhardt U; Lemmel EM
    Verh Dtsch Ges Inn Med; 1975; 81():1191-3. PubMed ID: 1229436
    [No Abstract]   [Full Text] [Related]  

  • 11. Teratogenicity and neonatal toxicity of ifosfamide in mice.
    Bus JS; Gibson JE; Reinke DA
    Proc Soc Exp Biol Med; 1973 Sep; 143(4):965-70. PubMed ID: 4743716
    [No Abstract]   [Full Text] [Related]  

  • 12. Separation of T and B lymphocytes and their role in the mixed lymphocyte reaction.
    von Boechmer H
    J Immunol; 1974 Jan; 112(1):70-8. PubMed ID: 4272924
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of immunosuppressive treatment on the in vitro activity of mouse lymphoid cells after stimulation by PHA and allogeneic cells.
    Snippe H; Bruijnzeel PL; Willers JM
    Int Arch Allergy Appl Immunol; 1973; 45(5):731-43. PubMed ID: 4270693
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunosuppression and induction of tolerance by 3-(2-chloroethyl)-2(2-mesyloxyethylamino)-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide (ASTA 5122)].
    Botzenhardt U; Lemmel EM
    Arzneimittelforschung; 1974 Aug; 24(8):1167-72. PubMed ID: 4154071
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic effects of cyclophosphamide, ifosfamide and trofosfamide.
    Mohn GR; Ellenberger J
    Mutat Res; 1976; 32(3-4):331-60. PubMed ID: 822325
    [No Abstract]   [Full Text] [Related]  

  • 16. Mixed leukocyte culture reactivity and chronic graft-versus-host reactions (secondary disease) between allogeneic H-2k mouse strains.
    Rodey GE; Bortin MM; Bach FH; Rimm AA
    Transplantation; 1974 Jan; 17(1):84-8. PubMed ID: 4148890
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of 137Cs irradiation and mitomycin C treatment of stimulator cells in the mixed lymphocyte culture reaction.
    Lightbody J; Kong YC
    Cell Immunol; 1974 Aug; 13(2):326-30. PubMed ID: 4281351
    [No Abstract]   [Full Text] [Related]  

  • 18. DNA replication in mixed lymphocyte culture.
    Lanotte M; Panijel J
    Nat New Biol; 1973 Sep; 245(141):41-4. PubMed ID: 4269657
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of normal allogeneic responder cells in mouse mixed leukocyte culture by long-passage AKR leukemic lymphoblasts.
    Rodey GE; Sprader JC; Bortin MM
    Cancer Res; 1974 Jun; 34(6):1289-94. PubMed ID: 4275007
    [No Abstract]   [Full Text] [Related]  

  • 20. Cellular immunity in the mouse. I. In vitro lymphocyte reactivity.
    Phillips SM; Carpenter CB; Merrill JP
    Cell Immunol; 1972 Oct; 5(2):235-48. PubMed ID: 4262839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.